Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats
Megalin has been proposed as an endocytic receptor for aminoglycosides as well as estrogen and androgen. We aimed to investigate the otoprotective effects of antiandrogens (flutamide, FM) on kanamycin (KM)-induced hearing loss in rats. Rats were divided into four groups. The KM group was administere...
Main Authors: | Kyung-Ju Chun, Chang-Ho Lee, Kyung-Woon Kim, So-Min Lee, So-Young Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/10/5307 |
Similar Items
-
Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss
by: Chang Ho Lee, et al.
Published: (2021-12-01) -
Correlation between the Length of Kanamycin Therapy and Hearing Threshold Shift in Multidrug Resistant Tuberculosis (MDR-TB) Patients
by: Abla G. Irwan, et al.
Published: (2017-12-01) -
Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review
by: Tae Jin Kim, et al.
Published: (2021-03-01) -
Salivary Duct Carcinoma in the External Auditory Canal Causing Ipsilateral Hearing Loss
by: Shih-Lung Chen, et al.
Published: (2021-07-01) -
Hearing loss among patients on treatment for drug-resistant tuberculosis in Uganda
by: Lodiong Jackson Dumo Lodiong, et al.
Published: (2021-08-01)